Skip to main navigation Skip to search Skip to main content

Convergent synthesis and biological evaluation of syringolin a and derivatives as eukaryotic 20S proteasome inhibitors

  • Jérôme Clerc
  • , Barbara Schellenberg
  • , Michael Groll
  • , André S. Bachmann
  • , Robert Huber
  • , Robert Dudler
  • , Markus Kaiser
  • Chemical Genomics Centre of the Max Planck Society
  • University of Zurich
  • University of Hawaii Cancer Center
  • Max Planck Institute of Biochemistry
  • University of Duisburg-Essen
  • Cardiff University

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Abstract

A convergent synthesis of SylA was developed and consists of the synthesis of a fully functionalized macrocycle, which is subsequently coupled with a urea moiety. For cyclization, ring-closing metathesis of a conformationally preorganized precursor was employed. The established synthetic route was then applied to the synthesis of SylA derivatives by using various peptidic side chains for decoration of the SylA macrocycle. The resulting collection of SylA analogues was tested for proteasome inhibition, revealing PEGylated SylA derivatives as the most potent proteasome inhibitors.

Original languageEnglish
Pages (from-to)3991-4003
Number of pages13
JournalEuropean Journal of Organic Chemistry
Issue number21
DOIs
StatePublished - Jul 2010

Keywords

  • Biological activity
  • Inhibitors
  • Metathesis
  • Natural products
  • Synthetic methods

Fingerprint

Dive into the research topics of 'Convergent synthesis and biological evaluation of syringolin a and derivatives as eukaryotic 20S proteasome inhibitors'. Together they form a unique fingerprint.

Cite this